Pilot, Phase 2 Study Assessing Intracranial Activity of AZD9291 (TAGRISSO) in Advanced EGFRm NSCLC Patients With Asymptomatic Brain Metastases
Phase of Trial: Phase II
Latest Information Update: 18 Oct 2017
At a glance
- Drugs Osimertinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 18 Oct 2017 Preliminary results (n=22; As of May 31 2017) presented at the 18th World Conference on Lung Cancer
- 19 Jun 2016 Status changed from not yet recruiting to recruiting.
- 20 Apr 2016 Number of arms changed from 1 to 2.